Mark Zuckerberg-Backed AI Startup Takes Over Parkinson’s Treatment From the Maker of OzempicGizmodoBruce GilMay 11, 2026, 01:15 PMView OriginalCellular Intelligence just acquired the rights to an experimental Parkinson’s cell therapy from Novo Nordisk.View OriginalBack to List
